Researchers reviewed the clinical characteristics of patients taking GLP-1 receptor agonists who develop NAION.

Investigators evaluated a deep learning model’s ability to identify ocular surface squamous neoplasia using optical coherence ...

Patients in the US with newly diagnosed GCA face excessive delays to initiating subcutaneous TCZ, as well high out-of-pocket costs.